Regis: Nu643 Module 7 Study Guide Graded A+

TSH/T4, BUN/Cr, electrolytes, Lithium level at wk, 1-2 mos and q6-12mos {Ans: Lab monitoring for Lithium}Lithium {Ans: Mood stabilizer known for anti-suicide effects}Lithium, Valproic Acid, Tegretal (usually) {Ans: Mood stabilizers dosed to therapeutic blood level}Symbyax, quetiapine, latuda {Ans: Medications FDA approved for treatment of bipolar depression}Benzodiazepines {Ans: Medication class used adjunctively to treat agitation, insomnia and incipient manic symptoms}Lithium {Ans: Mood stabilizer metabolized by kidneys}DRESS - multi organ hypersensitivity reaction syndrome {Ans: Adverse side effect characterized by rare occurrence of rash, fever, lymphadenopathy}Carbamazepine {Ans: Mood stabilizer with risk for skin reactions (but without black box warning)}CBC and LFT at baseline, 6weeks, q3 mos {Ans: Lab monitoring for Carbamazepine}Lamotrigine {Ans: Mood stabilizer initiated with slow upward dose titration}Valproic Acid {Ans: Mood stabilizer with risk of hepatotoxicity}Carbamazepine {Ans: Mood stabilizer that carries risk of hematologic abnormalities}Valproic Acid {Ans: Mood stabilizer with risk for polycystic ovary disease}Oxcarbazepine {Ans: Mood stabilizer considered second line to lithium and valprioc acid}Lithium {Ans: Mood stabilizer with long-term adverse effects on thyroid and kidneys}Suicide Risk {Ans: FDA Black box warning on anticonvulsants}LFTs, CBC with platelets at baseline, q6mos {Ans: Routine lab